Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
26.11
+0.64 (2.51%)
Jan 23, 2026, 3:00 PM CST
131.88% (1Y)
| Market Cap | 10.33B |
| Revenue (ttm) | 709.13M |
| Net Income (ttm) | 64.21M |
| Shares Out | 405.71M |
| EPS (ttm) | 0.16 |
| PE Ratio | 160.46 |
| Forward PE | 242.57 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,659,974 |
| Average Volume | 7,219,844 |
| Open | 25.80 |
| Previous Close | 25.47 |
| Day's Range | 25.30 - 26.58 |
| 52-Week Range | 11.11 - 34.68 |
| Beta | 0.53 |
| RSI | 47.32 |
| Earnings Date | Mar 20, 2026 |